We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 4 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 5 actions collected · 5 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 24. | Keefe, Bruyette & Woods | — | Maintain | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2026. 02. 09. | Piper Sandler | — | Downgrade | Overweight → Neutral | — | Piper Sandler: Overweight → Neutral |
| 2026. 01. 07. | Raymond James | — | Upgrade | Market Perform → Strong Buy | — | Raymond James: Market Perform → Strong Buy |
| 2025. 09. 02. | Keefe, Bruyette & Woods | — | Maintain | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2025. 08. 01. | Piper Sandler | — | Maintain | Neutral → Neutral | — | Piper Sandler: Neutral |
Past rating changes by firm, agreement/divergence within the sector, and what target changes mean.